Corteva has completed the 1:1 spinout of Vylor, creating a pure-play seed and genetics company on the NYSE.…
AstraZeneca is investing $2 billion in Summit Therapeutics and launching a trial collaboration around ivonescimab and Sone-Ve. The…
Fervo synchronized and exported electricity from the first 33-megawatt unit at Cape Station in Utah, a milestone for…
Anthropic’s first public life-sciences result suggests AI agents can materially compress genomic search and candidate triage. But the…

Archer’s proposed acquisition of Boeing’s autonomy and drone subsidiaries has cleared a key antitrust waiting-period step, but the…
TEKEVER says it has reached a first close of $580 million at a $6.4 billion valuation, days after…